Início › Câncer de Pulmão de Não Pequenas Células › Mississippi
Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Mississippi
20 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Mississippi.
Cidades em Mississippi
Texto oficial do estudo (Inglês)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Hattiesburg Clinic /ID# 248033, Hattiesburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT04928846Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- University of Mississippi Medical Center, Jackson
- e mais 3
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT04267848A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07293247A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Local Institution - 0180, Hattiesburg
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07680764Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- University of Mississippi Medical Center, Jackson
- e mais 3
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Baptist Cancer Center, Southaven
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07144280Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Hattiesburg Clinic Hematology/Oncology ( Site 0104), Hattiesburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06170788Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Hattiesburg Clinic Hematology/Oncology, Hattiesburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Jackson Oncology Associates, PLLC, Jackson
- Jackson Oncology Associates, PLLC, Jackson
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06758401Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Research Site, Hattiesburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06357533A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Hattiesburg Clinic Hematology/Oncology, Hattiesburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06561386Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Clinical Study Site, Hattiesburg
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06767514Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Jackson Oncology Associates - The Hederman Cancer Center, Jackson
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT04613596A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- North Mississippi Hematology and Oncology Associates, Tupelo
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- University of Mississippi Medical Center, Jackson
- e mais 3
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- e mais 2
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT06116682Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Gulfport Memorial Hospital, Gulfport
- e mais 3
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- e mais 2
RecrutandoFase 2
18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- e mais 2
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.